Search research articles
Contact Us
Filters
Showing results (141-150 of 175) with videos related to
Page
of 18
Sort By:
Blood Advances
|
October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma
Erica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Cell Systems
|
December 9, 2015
Optimizing cancer genome sequencing and analysis
Malachi Griffith, Christopher A Miller, Obi L Griffith, et al.
Science Immunology
|
June 28, 2024
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation
Jennifer A Foltz, Jennifer Tran, Pamela Wong, et al.
Cancer Cell
|
September 8, 2025
Large B cell lymphoma microenvironment archetype profiles
Xubin Li, Kartik Singhal, Qing Deng, et al.
The Journal of Clinical Investigation
|
June 6, 2023
T-BET and EOMES sustain mature human NK cell identity and antitumor function
Pamela Wong, Jennifer A Foltz, Lily Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Nature Communications
|
September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
Alex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Genome Biology
|
August 11, 2010
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
Steven Jm Jones, Janessa Laskin, Yvonne Y Li, et al.
Nature Communications
|
September 6, 2018
The prognostic effects of somatic mutations in ER-positive breast cancer
Obi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 175) with videos related to
Sort By:
Page
of 18
Blood Advances
|
October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma
Erica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Cell Systems
|
December 9, 2015
Optimizing cancer genome sequencing and analysis
Malachi Griffith, Christopher A Miller, Obi L Griffith, et al.
Science Immunology
|
June 28, 2024
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation
Jennifer A Foltz, Jennifer Tran, Pamela Wong, et al.
Cancer Cell
|
September 8, 2025
Large B cell lymphoma microenvironment archetype profiles
Xubin Li, Kartik Singhal, Qing Deng, et al.
The Journal of Clinical Investigation
|
June 6, 2023
T-BET and EOMES sustain mature human NK cell identity and antitumor function
Pamela Wong, Jennifer A Foltz, Lily Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Nature Communications
|
September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
Alex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Genome Biology
|
August 11, 2010
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
Steven Jm Jones, Janessa Laskin, Yvonne Y Li, et al.
Nature Communications
|
September 6, 2018
The prognostic effects of somatic mutations in ER-positive breast cancer
Obi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Page
of 18